Category: Funding

2017 Call for Applications: DPhil/PhD Transition Fellowships

EIT Health partners Oxford University, Imperial College London, Coimbra University and University of Lisbon are collaborating on an exciting competitive funding scheme focused on closing the gap between completion of the doctoral thesis and obtaining seed funding for innovative ideas, products and services based on the research.

From now until 16 June, Imperial College London is seeking applications from suitable Imperial DPhil/PhD candidates, whose innovative work would benefit from such a pre-seed (spark) award.

Find out more at: http://eithealth.eu/2017-call-applications-dphilphd-transition-fellowships/

Faculty Fellowships and Wellcome Trust visit

Faculty Fellowships

Faculty Fellowships are a new Wellcome Trust Institutional Strategic Support Fund opportunity, providing flexible funding for up to 18 months for early career researchers who have not yet submitted a Fellowship application but for who an award is in the pipeline because of the quality of the applicant, supervisor and project.

These fellowships are open to researchers across all Faculties. Postdoctoral researchers from disciplines outside of biomedicine can apply for funding to apply their expertise to the goals of understanding health and disease, provided the proposed area of research is within the remit of the Wellcome Trust.

The closing date for applications is 12.00 on 19 June 2017. Please note that within the Faculty of Medicine, the Departmental deadline is 1 June. Further details regarding these Fellowships can be found on the ISSF webpage. (more…)

Imperial Clinician Researcher Fellowship (Post-doc, Post-CCT) scheme

The new Imperial Clinician Researcher Fellowship (Post-doc, Post-CCT) scheme is now open for applications.  The purpose of the 2-year Fellowship is to draw on the research strengths of Imperial and attract the highest quality early stage clinical academics finishing clinical training to work towards Clinician Scientist, Wellcome Trust or other externally funded clinical research mid-level awards. (more…)

MRC ‘Confidence in Concept’ scheme

The College has been awarded £840,000 from the MRC ‘Confidence in Concept’ scheme to pump–prime the translation of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies toward clinical testing within the Imperial Academic Health Sciences Centre (AHSC). Included in this award is a ring-fenced fund of £125,000 for projects addressing the aims of the Global Challenges Research Fund. (more…)

Wellcome Trust Institute Strategic Support Fund

The College has been awarded £5M from Wellcome for the next five years, continuing the Institute Strategic Support Fund which has been instrumental in supporting wellcome-logo-blackbiomedical research across the College over the past 5 years.  The scheme has previously funded numerous internal funding streams targeting the enhancement of multidisciplinary research, the support of early career researchers, strategic initiatives enhancing support for priority themes and public engagement activities. Through strategic allocation of £7.5M funding since 2011/2012, the scheme has supported more than 380 investigators through 185 awards across the College and in turn leveraged a further £53M in follow-on funding.

In 2016/2017, the ISSF scheme will support Clinical Research Careers through Global Health Fellowships and Clinician Researchers schemes and non-clinical researchers through Faculty Fellowships.  The scheme will also support key initiatives to promote collaboration and will ensure the College is supporting an inclusive research environment. All opportunities for funding will be advertised on the internal funding opportunities webpage.

Dr Sarah Wagstaffe
Head of Research Strategy
Faculty of Medicine

NHLI creates videos for British Lung Foundation #BreatheEasy campaign

NHLI videos

As part of the British Lung Foundation’s campaign to raise awareness of what breathlessness may mean for your wider health, we highlighted the work of Dr Jennifer Quint and her team here at NHLI. We supported the #BreatheEasy campaign by doing a series of short videos where Jenni and her PhD student, Ann Morgan, talk about their BLF funded research.

The series of videos we created on this research is from the Respiratory Epidemiology group, and is using anonymised patient records to look at respiratory disease. By using simple questions on what the research was about, why it is important and its potential impact we hoped to make the research accessible to the wider public. We found the greatest engagement on twitter was with the simplest questions – “What is COPD?” was only beaten into second place by the promoted tweet pinned at the top of our homepage “Can you tell us what your research is about?”.

Watch the videos on YouTube

Helen Johnson
Communications and Website Officer
NHLI

Imperial Confidence in Concept (ICiC) Scheme Awards Funding to 25 projects

The Faculty is delighted to report the outcome of the fourth Imperial Confidence in Concept (ICiC) competition to support the College-wide development of novel devices, diagnostics and therapeutics for areas of unmet clinical need. A fund in excess of £1.6million was made available from the MRC (Confidence in Concept fund), NIHR Imperial BRC, Wellcome Trust Institutional Strategic Support Fund, EPSRC and BBSRC Impact Acceleration Accounts, as well as support from NIHR BRC at The Royal Marsden and The Institute of Cancer Research. The ICiC scheme provides vital pilot funding to bridge the potential gap between discovery research and well-developed applications for MRC Developmental Pathway Funding Scheme / Developmental Clinical Studies Funding Scheme support.

The Panel, including external members and chaired by Professor Roberto Solari, was delighted with the high quality and wide range of applications. Examples of the breadth of funded proposals include: ‘Preclinical assessment of a lead NMT inhibitor as a novel anticancer agent’ (Tate); ‘Development and validation of a 2 gene RNA test to detect bacterial infection’ (Levin); ‘A ‘smart’ ultrasonic focus for brain drug delivery’ (Choi); ‘GM-CSF gene therapy for pulmonary alveolar proteinosis’ (Griesenbach). We are also pleased to announce two co-funded projects with our colleagues at the NIHR BRC at The Royal Marsden and ICR; ‘The development of a high-throughput breathomics platform for oeosophago-gastric cancer’ (Hanna) and ‘The use of innovative spectroscopy technologies (i-Knife and DESI) for the improvement of the management of women with abnormalities in cervical screening’ (Kyrgiou). The first project is a collaboration between Prof George Hanna (ICL), Dr Andrea Romano (ICL), Prof David Cunningham (ICR), Mr Asif Chaudry (ICR), and Prof Paris Tekkis (ICR). The second project led by Dr Maria Kyrgiou involves collaboration with the Royal Marsden gynaecological oncology team (Mr Butler, Mr Ind, Mr Barton).

The investigators who will receive awards of up to £85,000 are:

  • Professor Eric Aboagye (PI), Dr Laurence Carroll, & Dr Kathrin Heinzmann (Department of Surgery & Cancer)
  • Dr Geoff Baldwin (PI) & Professor Edward Leen (Departments of Life Sciences and Medicine)
  • Dr Andrew Blagborough (PI) & Dr Fiona Angrisano (Department of Life Sciences)
  • Dr James Choi (PI) & Dr Matthew Williams (Department of Bioengineering and Imperial College Healthcare NHS Trust)
  • Dr Armando Del Rio Hernandez (PI) (Department of Bioengineering)
  • Dr Andrew Edwards (PI), Dr Thomas Clarke, Dr Thomas Webb, Dominic Marshall (Department of Medicine)
  • Dr Matthew Fuchter (PI), Prof Simak Ali, & Dr Geoff Baldwin (Departments of Chemistry, Surgery & Cancer, and Life Sciences)
  • Dr Nicholas Glanville (PI) & Professor Sebastian Johnston (National Heart & Lung Institute)
  • Professor Uta Griesenbach (PI) & Professor Eric Alton (National Heart & Lung Institute)
  • Professor George Hanna (PI) & Dr Andrea Romano (Department of Surgery & Cancer)
  • Dr Mark Isalan (PI) (Department of Life Sciences)
  • Dr Angela Kedgley (PI), Ms Donna Kennedy, Dr Tonia Vincent, & Dr Fiona Watt (Departments of Bioengineering and Surgery & Cancer and Imperial College Healthcare NHS Trust)
  • Dr Maria Kyrgiou (PI), Professor Zoltan Takats, Dr Sadaf Ghaem-Maghami, Professor Phillip Bennett, & Dr David Macintyre (Department of Surgery & Cancer)
  • Dr Gerald Larrouy-Maumus (PI), Professor Francis Drobniewski, Dr Brian Robertson, & Dr Vahid Shahrezaei (Departments of Life Sciences, Medicine, and Mathematics)
  • Professor Mike Levin (PI) & Dr Pantelis Georgiou (Departments of Medicine and Electrical & Electronic Engineering)
  • Dr George Mylonas (PI) & Professor Ara Darzi (Department of Surgery & Cancer)
  • Dr Alexandra Porter (PI), Professor Charles Coombes, Professor Mary Ryan, & Dr Fang Xie (Departments of Materials and Surgery & Cancer)
  • Professor Robin Shattock (PI) (Department of Medicine)
  • Professor Roberto Solari (PI) & Dr Andrew Bell (National Heart & Lung Institute and Department of Chemistry)
  • Professor Ed Tate (PI), Professor Eric Aboagye, Dr Andy Bell, & Dr Laura Kenny (Departments of Chemistry and Surgery & Cancer)
  • Dr Vasso Terzidou (PI), Dr David Macintyre, & Professor Phillip Bennett (Department of Surgery & Cancer)
  • Dr Ross Walton (PI), Professor Sebastian Johnston, & Dr Aoife Cameron (National Heart & Lung Institute)
  • Professor Peter Weinberg (PI) & Dr Mengxing Tang (Department of Bioengineering)
  • Professor Ramesh Wigneshweraraj (PI) & Dr Daniel Brown (Department of Medicine)
  • Dr Lan Zhao (PI) & Professor Martin Wilkins (Department of Medicine)

Dr Kimberley Trim
Research Strategy Coordinator
Faculty of Medicine

Call for 1-Year Clinical Training Fellowships in Global Health Research

We are looking to support outstanding early-career clinical professionals wishing to undertake research, at least in part overseas, to improve the health of people and reduce health inequalities in developed and developing countries. Through the provision of clinical training fellowships in global health, we aim to provide opportunities for the most promising clinical academics, at the very beginning of their careers, to develop bids for independent fellowship funding. We anticipate that each fellow will be supported by two mentors, one based at an Imperial Campus, and one based overseas. All fellowships must commence by 1 September, 2016.

How to apply?

Please refer to the Wellcome Trust Institutional Strategic Support Fund webpage for application forms and guidelines.

If you have an Imperial and overseas sponsor, please contact ISSF@imperial.ac.uk for an application form and further information. Should you be an interested applicant looking for a sponsor, please provide a max 500 word summary of your interests, brief summary of project and research experience to ISSF@imperial.ac.uk by 25 January 2016. We cannot guarantee that all interested applicants will be matched with an overseas sponsor. Full applications would need to be submitted by 4 March 2016 to ISSF@imperial.ac.uk. Interviews for shortlisted candidates are expected to take place the week commencing 2 May 2016.

This Fellowship program is funded through the Global Health Stream of the Wellcome Trust Institutional Strategic Support Fund, and lead by the Imperial Wellcome Trust Global Health Research Centre in conjunction with the Institute for Global Health Innovation.

For further information please contact:

Dr Kimberley Trim, Faculty of Medicine,
Imperial College London SW7 2AZ UK
Tel: 020 7594 9826
E-mail: ISSF@imperial.ac.uk

Committed to equality and valuing diversity. We are also an Athena SWAN Silver Award winner, a Stonewall Diversity Champion, a two Ticks Employer and are working in partnership with GIRES to promote respect for trans people.

New research to investigate models of child health care in Europe

Professor Mitch Blair and Professor Michael Rigby from the Section of Paediatrics of the Faculty of Medicine at Imperial, together with European colleagues, have been awarded almost 7 million Euro by the European Commission – Directorate General for Research and Innovation Horizon 2020 programme to study and evaluate models of child primary care in Europe.

Professor Mitch Blair
Professor Mitch Blair

The project: MOCHA Models of Child Health Appraised will see Imperial College project staff working with 19 scientific partners from 10 European countries, plus Switzerland, the United States and Australia; as well as with country agents in 30 European Commission and European Economic Area countries.

The project began on 1st June with a three-month preparation phase, including creating a project website, prior to an active research programme commencing on 1st September 2015 continuing until the late autumn of 2018.

Principal Investigator Professor Blair explained:

“Children are an important population group in their own right, but also are the future of Europe, its society and its workforce. Thus children’s health is vital to children and for a healthy Europe”.

“However, there is no consensus on the best way of providing primary health care for children. Different countries favour different models, of which two main ones are generalist general practitioners seeing the child in the family context, and primary care paediatricians with focused expertise. Until now there is no research which shows which model is most effective, which also implies that some children are likely to be receiving sub-optimal care.”

MOCHA will obtain and analyse key information on a range of child primary care topics, such as:

  • Models of primary care delivered to children (including urgent care)
  • Delivery of care across organisational boundaries (with secondary care, social care, education and so on) including complex care, and services for child protection
  • School health services, and direct access services for adolescents
  • Identification of innovative measures of quality and outcome
  • Identification of derivatives from large data sets to measure quality and outcome
  • Economic and Skill Set analyses
  • Ensuring Equity for all children
  • Use of electronic records in child health
Professor Michael Rigby
Professor Michael Rigby

An independent Expert Panel from 10 countries and 15 different organisations or paediatric and public health associations will validate the scientific enquiries made of country agents, and review the findings. Views of service users will be sought throughout the project, and there will be an active engagement and dissemination programme.

The project will be managed from Imperial College, coordinating the work of 11 separate work packages run by experts from European research institutions, including researchers from Imperial College.

This will be one of the largest and most ambitious project to look at child health services in Europe. Focusing on prevention and wellness, its results will demonstrate the optimal model(s) of child primary care. Alongside the results, the MOCHA project will analyse the factors (including cultural factors) which might facilitate the adoption of recommendations, and indications for policy makers of both the health and economic gains possible. Throughout its life, the project will have a strong dissemination programme, ensuring that dialogue with the public, professionals, policy makers and politicians is maintained and taken into account during the research.

Within its 42-month timescale, the MOCHA project will deliver major awareness and potential benefit for European children’s health and a healthy society.

For further details contact:

Leaders: Prof. Mitch Blair – m.blair@imperial.ac.uk ; Prof. Michael Rigby – m.rigby@imperial.ac.uk or
Research Fellow (Scientific Coordinator): Denise Alexander – d.alexander@imperial.ac.uk

Waljit Dhillo awarded prestigious NIHR Research Professorship

Professor Waljit Dhillo
Professor Waljit Dhillo

Waljit Dhillo, Professor in Endocrinology & Metabolism and Consultant Endocrinologist, has been awarded a prestigious National Institute for Health Research (NIHR) Research Professorship, in the 2015 competition.

NIHR Research Professorships aim to fund leaders in the early part of their careers to lead research, to promote effective translation of research (‘bench to bedside [T1] and ‘campus to clinic’ [T2]) and strengthen research leadership at the highest academic levels. NIHR Research Professorships are prestigious awards for researchers who have an outstanding record of clinical and applied health research, and its effective translation for improved health.

Speaking about his project, entitled ‘Using hormones to improve reproductive health’, Professor Dhillo said:

Disorders of reproductive health affect millions of patients worldwide. The hormones kisspeptin and neurokinin B have recently been identified as potential novel targets for the treatment of infertility and menopausal flushing, respectively. My programme of work aims to develop novel treatment protocols based on kisspeptin and neurokinin B to treat patients with disorders of reproductive health.

Imperial Confidence in Concept (ICiC) scheme awards funding to 22 projects

The Faculty is delighted to report the outcome of the third Imperial Confidence in Concept (ICiC) competition to support the College-wide development of novel devices, diagnostics and therapeutics for areas of unmet clinical need. A fund in excess of £1.3million was made available from the MRC (Confidence in Concept fund), NIHR Imperial BRC, Imperial Innovations, Wellcome Trust Institutional Strategic Support Fund, EPSRC Impact Acceleration Account and as well as support from NIHR BRC at The Royal Marsden and The Institute of Cancer Research and Chelsea & Westminster Hospital NHS Foundation Trust. This is the first year that Chelsea & Westminster Hospital NHS Foundation Trust has taken part in the scheme.  The ICiC scheme provides vital pilot funding to bridge the potential gap between discovery research and well-developed applications for MRC Developmental Pathway Funding Scheme / Developmental Clinical Studies Funding Scheme support. The Panel, including external members and chaired by Professor Roberto Solari, was delighted with the high quality and wide range of applications. 22 Awards were made.

The investigators who will receive awards of up to £70,000 are:

Professor Andrew Amis (PI), Professor Justin Cobb, & Dr Ferdinando Rodriguez Y Baena (Departments of Mechanical Engineering and Surgery & Cancer)

Dr Reza Bahmanyar (PI, Department of Electrical & Electronic Engineering)

Dr Jeffrey Bamber (PI) & Dr Mengxing Tang (Division of Radiotherapy & Imaging, Institute of Cancer Research and Department of Bioengineering, ICL)

Dr Paul Bentley (PI), Professor Etienne Burdet, & Dr Michael Mace (Departments of Medicine & Bioengineering)

Professor Thomas Brand (PI) & Dr Katie Chapman (National Heart & Ling Institute and Domainex Ltd)

Dr Graham Cooke (PI), Professor Chris Toumazou, & Professor Myra McClure (Departments of Medicine & Bioengineering)

Dr Ernesto Cota Segura (PI), Dr Nathan Brown, Professor Ed Tate, & Dr Chiara Recchi (Departments of Life Sciences, Chemistry, Surgery & Cancer, and CRUK Cancer Therapeutics Unit, Institute of Cancer Research)

Dr Christina Fotopoulou (PI) & Dr Paula Cunnea (Department of Surgery & Cancer)

Professor Gary Frost (PI), Dr Rohini Sharma, Professor Mark Thursz, & Dr Edwards Chambers (Department of Medicine)

Professor George Hanna (PI), Dr Tanzeela Khalid, & Dr Melody Ni (Department of Surgery & Cancer)

Dr David Hodson (PI) & Professor Guy Rutter (Department of Medicine)

Professor David Klug (PI) & Dr Oscar Ces (Department of Chemistry)

Dr Christoph Lees (PI) & Professor Phil Bennett (Department of Surgery & Cancer)

Professor Nicholas Long (PI) & Professor Guy Rutter (Departments of Chemistry & Medicine)

Dr Stepan Lucyszyn (PI) & Professor Anthony Chu (Departments of Electrical & Electronic Engineering and Medicine)

Professor Danilo Mandic (PI) & Dr Sudhin Thayyil (Departments of Electrical & Electronic Engineering and Medicine)

Professor Jane Mitchell (PI), Dr Nicholas Kirkby, & Dr Mark Paul-Clark (National Heart & Lung Institute)

Dr Christopher Rhodes (PI) & Professor Martin Wilkins (Department of Medicine)

Professor Andrew Rice (PI) & Dr Kenji Okuse (Chelsea & Westminster Hospital, Departments of Surgery & Cancer and Life Sciences)

Professor Molly Stevens (PI), Dr Anthony Gordon, & Dr Robert Chapman (Departments of Materials, Bioengineering, and Surgery & Cancer)

Professor Ed Tate (PI), Professor Sebastian Johnston, & Dr Aurelie Mousnier (Department of Chemistry and National Heart & Lung Institute)

Dr Paul Turner (PI), Dr Mohamed Shamji, & Dr Robert Boyle (Department of Medicine and National Heart & Lung Institute)

 

Dr Kimberley Trim
Research Strategy Coordinator
Faculty of Medicine

Antimicrobial Research Collaborative (ARC) Early Career Research Fellowships

The Antimicrobial Research Collaborative (ARC) is a new Imperial network of researchers, primary care specialists and allied health professionals established to advance basic research in AMR and to translate research to novel prevention strategies and healthcare interventions. The ARC Early Career Research Fellowships scheme aims to attract and retain the most promising early career scientists to undertake multidisciplinary research projects in antimicrobial research within the College.

How to apply?

Full details of the ARC Early Career Research Fellowships and how to apply will be announced on 5th June, and will be available from: http://www.imperial.ac.uk/research-and-innovation/funding-opportunities/internal-funding-opportunities/issf/ There will be an opportunity to ask questions about the Fellowships at the ARC launch on 5th June (please see https://eventbrite.co.uk/event/17028140627/ for details of the event and to register). The closing date for ARC Fellowship applications will be 5pm on 3rd July 2015.

Creating new opportunities for collaboration – pharma speed dating

On 30th January 2015, the breakout space at the Wolfson Education Centre at Imperial’s Hammersmith campus was buzzing with more than 100 dates between 40 Imperial academics from different faculties, and representatives from 7 major Pharma companies.

The first Pharma speed dating @ ICL event was part of the launch program for the Imperial Confidence in Concept funding scheme, and was organized by the Corporate Partnerships team. Jonathan Weber, Vice-Dean of Research and Imperial College AHSC Director said

“The Pharma speed dating event fits with our strategy to strengthen Imperial relationship with the Pharmaceutical industry and to provide young PIs an opportunity to have their first industrial interactions”.

Academics had only 20 minutes to pitch their ideas to company representatives and discuss common interest for collaborations.

Both academics and company representatives enjoyed a day of interesting and open scientific discussions.

Silvia Santos, a starting group leader at the Imperial MRC-Clinical Science Centre said:

It was very informative to understand what a therapeutic target is to Pharma companies and the path to get into having a potential interesting target. But perhaps even more exciting was realising how complementary our approaches in the lab are with some of the companies and start discussions for potential collaborations.”

Following on from the event, the Corporate Partnerships team is busy following up with several companies who have opened opportunities for collaboration with the College.

The Corporate Partnerships team is expecting to run this event again next year. If your company is interested in participating in the next speed dating @ ICL event, please get in touch with us at enterprise-fom@imperial.ac.uk.

Call for Experimental Medicine Proposals 2015: NIHR Imperial BRC Institute of Translational Medicine and Therapeutics (ITMAT)

With the launch of ITMAT the NIHR Imperial BRC is pleased to announce an inaugural call for experimental medicine proposals to exploit ITMAT’s core platform technologies. It aims to promote and encourage the ‘pull-through’ of discovery science from the Faculties of Medicine, Engineering and Natural Sciences within Imperial College London into potential clinical applications.

The intention of this call is to provide seed funding support to pilot experimental medicine projects that are based on a workable hypothesis and can demonstrate reasonable promise of success. Our aim is to provide a boost to these promising projects, to provide the additional data and evidence that will support Imperial researchers to apply for larger, follow-on grants from other funders within a period of 12-15 months.

 

Applications should be made on the downloadable application form and submitted by 12pm on 4 May 2015 to brcofficer@imperial.ac.uk

View guidance documentation for this call

Find answers to Frequently Asked Questions about this call

 

What is ITMAT?

The Institute for Translational Medicine and Therapeutics (ITMAT) at NIHR Imperial Biomedical Research Centre (BRC) is virtual institute built upon core facilities across the College and Trust. Its aim is to support the acceleration of fundamental discoveries into improvements in human health and economic benefit.

ITMAT includes platforms in genomic (and metagenomic), metabonomic and imaging technologies and health informatics, as well as the NIHR Wellcome Trust Imperial Clinical Research Facility (ICRF) and one of the largest tissue collections in Europe. ITMAT offers BRC co-funding for proof-of-concept studies across the translational divide, and postgraduate programmes at the interface of basic and clinical sciences. The Institute particularly promotes multidisciplinary research, pulling through biomedical applications from engineering and physical sciences discovery science, and strategic commercial partnerships.

More information about the core platforms of ITMAT is detailed in Annex 1 of the guidance documentation.

Wellcome Trust Institutional Strategic Support Fund (ISSF) Networks of Excellence

Wellcome Trust Institutional Strategic Support Fund (ISSF) Networks of Excellence
Wellcome Trust Institutional Strategic Support Fund (ISSF) Networks of Excellence

We are seeking to support novel biomedical research collaborations across disciplines and departments. Proposals for pilot or feasibility work for high risk projects, to support collaborative cohesion, to test or develop new methods, or proof of concept studies are encouraged through this call. It is envisaged that the outcomes of supported work will then form the basis of a major grant application. Whilst funding is available to support any research within the remit of the Wellcome Trust, networks undertaking interdisciplinary research in the themes of Biomedical Engineering, Global Health and Development (including Epidemiology, Prevention and Control) and Infection Research (including Antimicrobial Strategies and Resistance) are particularly encouraged.

How to apply?

If you wish to submit a proposal you should complete the project application form and submit it to ISSF@imperial.ac.uk by the 12noon, 8 May 2015. As we wish to fund a range of applications, a researcher cannot be principal investigator on more than one application, though this will not preclude applicants from being co-applicants on additional proposals. For further information please email ISSF@imperial.ac.uk or see the Networks of Excellence guidelines available at http://www.imperial.ac.uk/research-and-innovation/funding-opportunities/internal-funding-opportunities/issf/

 

Dr Kimberley Trim
Research Strategy Coordinator
Faculty of Medicine

SCI selected to receive donations from MaxMind

SCI has been selected to receive donations this year from MaxMind, an industry-leading provider of IP intelligence and online fraud detection tools, based in Waltham, Massachusetts. SCI was selected on the strength of the Givewell recommendation (www.givewell.org ).

The donations will be used to expand SCI’s coverage of treatments for school aged children against schistosomiasis and intestinal worms in rural areas of Africa. By supporting these treatments, MaxMind will be bringing improved health and education to millions of vulnerable children.

alanfenwick-profilepic

Professor Alan Fenwick OBE
Professor of Tropical Parasitology
School of Public Health
Faculty of Medicine

 

 

Partnership for Child Development November 2014 Update

PCD Receives Grant for Global Health & Development

PCD  has been recently awarded by Grand Challenges Explorations an initiative funded by the Bill & Melinda Gates Foundation for a project focused on improving market information among stakeholders of Kenya’s school feeding programme. The programme is a government-led intervention which procures food used in school meals locally from smallholder farmers and has been described as a ‘win-win’ for both children and farmers alike; with well-fed children more likely to attend and stay in school and farmers more secured of a livelihood. Specifically, the project will develop a software platform using everyday items such as mobile phones, to improve the tendering process between the programme’s stakeholders, namely, the schools (buyers), traders (buyers and sellers) and farmer groups (sellers).

Click here to read more

School-Based Deworming: A Clear Role for the European Commission

School-based-deworming-image-of-policy-paper-edit Periodic drug treatment for children in schools – known as school-based deworming – represents a highly strategic approach to tackling soil-transmitted helminths (STH) and schistosomiasis. Integrated programmes that deliver deworming, water, sanitation and hygiene (WASH), health education and other key interventions lead to even greater long-term impact.

A new paper called ‘School-Based Deworming’ (PDF download 2.8mb), from Imperial College London’s Partnership for Child Development argues that the European Commission (EC) is on the margins of the growing global movement against NTDs and with its financial resources, technical capacity and global network, the EC can and should be at the forefront of efforts to tackle the diseases, in particular schistosomiasis and STH. In order to rise to this task, the EC requires a clear policy direction, and must ensure that the control and elimination of schistosomiasis and STH are integrated into its education, nutrition and WASH strategies and programmes.

Click here to read more

Charlotte Broyd
Communications Officer
Partnership for Child Development
Department of Infectious Disease Epidemiology

ISSF Networks of Excellence Scheme Awards Funding to 12 projects

The Faculty is delighted to report the outcome of the third annual Networks of Excellence competition to foster collaborative biomedical research endeavours across the Faculties of Medicine, Engineering, Natural Sciences and the Business School. The scheme is supported by the Wellcome Trust Institutional Strategic Support Fund (ISSF) and comprises matched funding from the College; a total fund in excess of £900K was made available to support novel, interdisciplinary biomedical research.  The Networks of Excellence scheme provided funding to support: pilot or feasibility work for high risk projects,collaborative cohesion, testing or development of new methods,or proof of concept studies. Funding was available for all research within the Wellcome Trust remit; proposals addressing interdisciplinary research in infectious diseases, medical imaging, and diabetes/metabolic medicine were particularly encouraged.

Applications were assessed by the Cross-College ISSF working group, chaired by Professor Simon Taylor-Robinson, and shortlisted applications considered for funding by the Vice Provost (Research) with the Cross-College Research Proposal Review Group. The Chair was delighted with the high quality of the 46 interdisciplinary applications received.  Examples of the breadth of funded proposals include: ‘Visualising bacterial infection in adult zebrafish with novel infrared protein fluorophores’ (Ulijasz), ‘Reducing health impacts from excess sodium intake in coastal SE Asia using novel water treatment technologies’ (Butler), ‘Targeted nanoparticles for preclinical diagnostic imaging of Parkinson’s disease’ (Dunlop), ‘Using Functionalised Nanorods in Theranostics’ (Wilton-Ely).

The investigators who will receive awards of up to £100,000 are:

Dr Adrian Butler (PI), Professor Paolo Vineis, Dr Simon Buckle, Professor Matin Ahmed, & Dr Dewan Alam (Department of Civil & Environmental Engineering, School of Public Health, Grantham Institute for Climate Change, University of Dhaka, International Centre for Diarrhoeal Disease Research)

Dr James Choi (PI), Professor Justin Stebbing, Dr Adrian Lim, & Dr Mengxing Tang (Departments of Bioengineering, Surgery & Cancer, and Medicine)

Professor Justin Cobb (PI), Dr Victoria Manning, Dr Patrick Naylor, Mr Toni Castells-Delgado, Dr Edouard Auvinet, Ms Michela Zanotto (Departments of Surgery & Cancer and Electrical & Electronic Engineering and School of Professional Development)

Dr Iain Dunlop (PI), Professor David Dexter, Dr Alexandra Porter & Dr Roberto Fiammengo (Departments of Materials and Medicine plus Italian Institute of Technology)

Dr Ben Glocker (PI), Professor Daniel Rueckert, Professor Andrew Davison, Mr Philip Noonan, Professor Roger Gunn, & Professor Nicholas Peters (Department of Computing, Imanova Imaging Centre, and National Heart & Lung Institute)

Professor Nicholas Peters (PI), Professor Kim Christensen, Dr Daniel Rueckert, Professor Spencer Sherwin, Dr Prapa Kanagaratnam, Dr Phang Boon Lim, & Dr Fu Siong Ng (National Heart & Lung Institute, Departments of Electrical & Electronic Engineering, Computing, and Aeronautics)

Professor Robin Shattock (PI), Dr Cleo Kontoravdi , Dr Karen Polizzi, Dr Stuart Haslam, Dr Paul McKay, & Dr Eric Arts (Departments of Medicine, Chemical Engineering, and Life Science plus Case Western Reserve University)

Dr Paul Strutton (PI), Professor Alison McGregor, Professor David Sharp, Professor Andrea Rockall, Dr Ben Glocker, & Dr Rex Newbould (Departments of Surgery & Cancer, Medicine, and Computing)

Dr Andrew Ulijasz (PI), Professor Paul French, Professor Maggie Dallman, & Dr James McGinty (Departments of Medicine, Physics, and Life Sciences)

Dr Chris Wadsworth (PI) & Professor Richard Syms (Department of Medicine and Electrical & Electronic Engineering)

Dr James Wilton-Ely (PI), Professor Tony Cass, & Dr Dan Elson (Departments of Chemistry and Surgery & Cancer)

Dr Fang Xie (PI), Professor Eric Aboagye, Professor Mary Ryan, & Dr Alexandra Porter (Departments of Materials and Surgery & Cancer)

Dr Kimberley Trim
Research Strategy Officer
Faculty of Medicine

Longitude Prize 2014 launched

The BBC launched the Longitude Prize 2014 on Monday 19 May, announcing the six challenge themes:

  • Flight – low carbon
  • Food security – nutritious, sustainable
  • Antibiotics resistance
  • Paralysis – assistive tech/neuro advances etc
  • Water – clean, safe access etc
  • Dementia – assistive tech etc

£10M is available over 5 years to demonstrate proof of concept and ability to scale. All of the 6 challenge themes map to Imperial activities and expertise! 

Tony Hall, Lord Rees Brian Cox, Kevin Fong and Attenborough were all there to launch the Prize. Lord Rees Chairs the committee which has short-listed the six themes.

The Longitude Prize 2014 has been set up by the BBC, Nesta and the TSB, to mark 300 years since the (original) Longitude Prize.

Find out more about the challenges: http://www.bbc.co.uk/news/science-environment-27425224

Details were broadcast on the One Show and on a special Horizon episode (celebrating 50 years of Horizon), after which, voting opened. The nation gets to vote on the six challenge areas, with only the most popular being tackled. The chosen theme will be announced 25 June.

Dr Claire Thorne
Executive Coordinator to Professor David Gann CBE, Vice President (Development and Innovation)

Wellcome Trust Institutional Strategic Support Fund Networks of Excellence – deadline 12-noon, 9 May 2014

We are seeking to support novel biomedical research collaborations across disciplines and departments. Proposals for pilot or feasibility work for high risk projects, to support collaborative cohesion, test or develop new methods, or proof of concept studies are encouraged, rather than standard projects.  It is envisaged that the outcomes of supported work will form the basis of a major grant application. Whilst funding is available to support any research within the remit of the Wellcome Trust, networks undertaking interdisciplinary research in the themes of infectious disease, medical imaging and diabetes/metabolic medicine are particularly welcome.

How to apply?

If you wish to submit a proposal you should complete the project application form and submit it to ISSF@imperial.ac.uk by the 12noon, 9th May 2014. As we wish to fund a range of applications, a researcher cannot be principal investigator on more than one application, though this will not preclude applicants from being co-applicants on additional proposals. For further information please email ISSF@imperial.ac.uk or see the Networks of Excellence guidelines available at http://www3.imperial.ac.uk/researchstrategy/funding/wtissf

Dr Kimberley Trim
Research Strategy Officer
Faculty of Medicine

Imperial Confidence in Concept Showcase Event – 17th Feb 2014

The second call of the Imperial Confidence in Concept (ICiC) was launched in January 2014. Building on the success of the 2013 ICiC scheme and NIHR Imperial Biomedical Research Centre (BRC) / Imperial Innovations Therapeutic Primer Fund, the College has received further funding from the Medical Research Council (MRC), as well as additional support from NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research, to continue this scheme. The ICiC scheme provides pilot funding to bridge the potential gap between discovery research and well-developed applications for MRC Biomedical Catalyst: Developmental Pathway Funding Scheme support.

Confidence in Concept event 17.02.2014   051

The annual ICiC event was held on Monday 17th February in The Great Hall on South Kensington Campus. This year’s event was focussed on devices and diagnostics and was a great success, attended by approximately 100 academics across the College. Attendees included recipients of awards from last year’s scheme and early career researchers who showcased their ICiC-funded work.

This cross-College event had a wide range of speakers including representatives from the Faculties of Engineering (Prof Andrew Amis), Medicine (Prof George Hanna), and Natural Sciences (Profs Tony Cass and Paul French) as well as our collaborators at the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (Prof Stan Kaye, Drs Nicola Valeri and Gert Attard).

The talks were engaging, informative and stimulating and special thanks goes to our external speakers Dr Helen Lee (University of Cambridge) and Dr Ray Bacon (CEO, TRIG1) for sharing their experiences of device and diagnostic development for commercial use with their talks entitled ‘Challenges in developing diagnostics for resource-limited settings’ (Lee) and ‘Commercial…is not a dirty word’ (Bacon).

The deadline for applications was 5th March with shortlisting due to take place at the end of March and final funding decisions to be made in May.

Dr Kimberley Trim
Research Strategy Officer
Faculty of Medicine

Wellcome Trust Institutional Strategic Support Fund Networks of Excellence

We are seeking to support novel, interdisciplinary biomedical research collaborations in the themes of infectious disease, medical imaging and diabetes/metabolic medicine. This is a cross-College scheme that welcomes any proposal to offer greater collaboration across disciplines and across departments. Proposals for pilot or feasibility work for high risk projects, to support collaborative cohesion, test or develop new methods, or proof of concept studies are encouraged, rather than standard projects. It is envisaged that the outcomes of supported work will form the basis of a major grant application. Whilst funding is available to support any research within the remit of the Wellcome Trust, networks undertaking interdisciplinary research inin the themes of infectious disease, medical imaging and diabetes/metabolic medicine are particularly welcome. It is envisaged that the outcomes of this work will form the basis of a major grant application. This scheme will be launched the week beginning 17th March 2014 with a deadline of 9th May 2014.

How to apply?

If you wish to submit a proposal you should complete the project application form and submit it to ISSF@imperial.ac.uk by the deadline9th May 2014. As we wish to fund a range of applications, a researcher cannot be principal investigator on more than one application, though this will not preclude applicants from being co-applicants on additional proposals. For further information please email ISSF@imperial.ac.uk or see the Networks of Excellence guidelines available at http://www3.imperial.ac.uk/researchstrategy/funding/wtissf 

Dr Kimberley Trim
Research Strategy Officer
Faculty of Medicine

ISSF Global Health Clinical Training Fellowships & Imperial Confidence in Concept scheme

ISSF Global Health Clinical Training Fellowships

We are seeking to support outstanding early-career clinical professionals wishing to undertake research, at least in part overseas, to improve the health of people and reduce health inequalities in developed and developing countries. Cross-disciplinary applications are encouraged.

These training fellowships are intended to provide opportunities for the most promising clinical academics, at the very beginning of their careers, to develop bids for independent fellowship funding. The primary aim of the fellowships is to remove obstacles to achieving peer-reviewed external grant or fellowship funding, through supporting feasibility or exploratory studies, facilitating networks and providing mentoring support from a senior Imperial academics. We anticipate that each fellow will be supported by two mentors, one based at an Imperial Campus, and one based overseas. All fellowships must commence by the 1st September, 2014.

How to apply?

If you have an Imperial and overseas sponsor, please contact ISSF@imperial.ac.uk for an application form and further information.

Should you be an interested applicant with a UK-based Imperial sponsor looking for an overseas sponsor, please provide a max 500 word summary of your interests, brief summary of project and research experience to ISSF@imperial.ac.uk. We cannot guarantee that all interested applicants with a UK-based sponsor will be matched with an overseas sponsor. Full applications would need to be submitted by 10th March 2014 to ISSF@imperial.ac.uk. Interviews for shortlisted candidates are expected to take place the week commencing 28th April 2014.

Imperial Confidence in Concept scheme

The second call for our Imperial Confidence in Concept (ICiC) scheme will be advertised next week. This initiative helps fast track promising research ideas towards a marketable product and/or clinical testing. Building on the success of the 2013 Imperial Confidence in Concept scheme and Imperial NIHR Biomedical Research Centre (BRC)/Imperial Innovations Therapeutic Primer Fund (£250,000), the College has received a further £700,000 funding from the Medical Research Council (MRC) to continue this scheme. The ICiC scheme provides pilot funding to bridge the potential gap between discovery research and well-developed applications for MRC Developmental Pathway Funding Scheme/ Developmental Clinical Studies Funding Scheme support.

An ICiC event will be held on the afternoon of Monday 17th February which will be open to all researchers within Imperial College and will require registration. This will include internal speakers as well as external speakers from the commercial sector and collaborators from the NIHR Royal Marsden/Institute of Cancer Research BRC. Further details will be circulated to faculties and departments the week beginning 27th January.

 

Dr Kimberley Trim
Research Strategy Officer
Faculty of Medicine